Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
10 p, 680.7 KB Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma / Ahmed, Sairah (University of Texas) ; Kanakry, Jennifer A. (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ; Ahn, Kwang Woo (Medical College of Wisconsin) ; Litovich, Carlos Alejandro (Medical College of Wisconsin) ; Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ; Aljurf, Mahmoud Deeb (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Bacher, Vera Ulrike (Inselspital. Bern University Hospital) ; Bejanyan, Nelli (Immunotherapy. Moffitt Cancer Center) ; Cohen, Jonathon B. (Emory University School of Medicine) ; Farooq, Umar (University of Iowa Hospitals and Clinics) ; Fuchs, Ephraim Joseph (The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins) ; Bolaños-Meade, Javier (The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins) ; Ghosh, Nilanjan S. (Levine Cancer Institute. Atrium Health) ; Herrera, Alex F. (City of Hope National Medical Center) ; Hossain, Nasheed (Loyola University Chicago-Stritch School of Medicine) ; Inwards, David (Mayo Clinic) ; Kanate, Abraham Sebastian (West Virginia University) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Munshi, Pashna (Georgetown University Hospital) ; Murthy, Hemant S. (University Florida College of Medicine) ; Mussetti, Alberto (Institut Català d'Oncologia-Hospitalet) ; Nieto, Yago (University of Texas) ; Perales, Miguel-Angel (Memorial Sloan Kettering Cancer Center) ; Romee, Rizwan (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Seo, Sachiko (Dokkyo Medical University) ; Wirk, Baldeep Mona (Seattle Cancer Care Alliance) ; Yared, Jean A. (University of Maryland) ; Sureda, Anna (Institut Català d'Oncologia-Hospitalet) ; Fenske, Timothy S. (Medical College of Wisconsin) ; Hamadani, Mehdi (Medical College of Wisconsin) ; Universitat Autònoma de Barcelona
Classic Hodgkin lymphoma (cHL) patients with relapsed or refractory disease may benefit from allogeneic hematopoietic cell transplantation (allo-HCT), but many lack a matched sibling donor (MSD). Herein, we compare outcomes of 2 reduced-intensity conditioning (RIC) HCT platforms in cHL: T cell-replete related donor haploidentical (haplo) HCT with a post-transplant cyclophosphamide (PTCy)-based approach versus an MSD/calcineurin inhibitor (CNI)-based approach. [...]
2019 - 10.1016/j.bbmt.2019.05.025
Biology of blood and marrow transplantation, Vol. 25 Núm. 9 (september 2019) , p. 1859-1868  
2.
10 p, 523.7 KB Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide / Im, Annie (University of Pittsburgh/UPMC Hillman Cancer Center) ; Rashidi, Armin (University of Minnesota) ; Wang, Tao (Medical College of Wisconsin) ; Hemmer, Michael (Medical College of Wisconsin) ; MacMillan, Margaret L. (University of Minnesota) ; Pidala, Joseph (H. Lee Moffitt Cancer Center and Research Institute) ; Jagasia, Madan (Vanderbilt University Medical Center) ; Pavletic, Steven (National Cancer Institute of Bethesda) ; Majhail, Navneet S. (Cleveland Clinic Taussig Cancer Institute) ; Weisdorf, Daniel (University of Minnesota) ; Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ; Agrawal, Vaibhav (Indiana University School of Medicine) ; Al-Homsi, A.Samer (New York University Langone Medical Center) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Askar, Medhat (Baylor University Medical Center) ; Auletta, Jeffery J (Nationwide Children's Hospital) ; Bashey, Asad (Blood and Marrow Transplant Program at Northside Hospital) ; Beitinjaneh, Amer (University of Miami) ; Bhatt, Vijaya Raj (University of Nebraska Medical Center) ; Byrne, Michael (Vanderbilt University Medical Center) ; Cahn, Jean-Yves (CHU Grenoble Alpes) ; Cairo, Mitchell S (New York Medical College) ; Castillo, Paul (UF Health Shands Children's Hospital) ; Cerny, Jan (University of Massachusetts Medical Center) ; Chhabra, Saurabh (Medical College of Wisconsin) ; Choe, Hannah (The Ohio State University Wexner Medical Center) ; Ciurea, Stefan (The University of Texas MD Anderson Cancer Center) ; Daly, Andrew (Tom Baker Cancer Center) ; Perez, Miguel Angel Diaz (Hospital Infantil Universitario Nino Jesus) ; Farhadfar, Nosha (University of Florida College of Medicine) ; Gadalla, Shahinaz M. (NIH-NCI Clinical Genetics Branch) ; Gale, Robert (Imperial College London) ; Ganguly, Siddhartha (University of Kansas Health System) ; Gergis, Usama (Thomas Jefferson University) ; Hanna, Rabi (Cleveland Clinic Foundation) ; Hematti, Peiman (University of Wisconsin) ; Herzig, Roger (University of Kentucky Chandler Medical Center) ; Hildebrandt, Gerhard C. (University of Kentucky) ; Lad, Deepesh P. (Postgraduate Institute of Medical Education and Research) ; Lee, Catherine (University of Utah) ; Lehmann, Leslie (Dana-Farber Cancer Institute/Boston Children's Hospital) ; Lekakis, Lazaros (University of Miami) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Kharfan-Dabaja, Momamed A. (Mayo Clinic) ; Khandelwal, Pooja (University of Cincinnati) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Murthy, Hemant S. (Mayo Clinic) ; Nishihori, Taiga (Moffitt Cancer Center) ; O'Brien, Tracey A. (Sydney Children's Hospital) ; Olsson, Richard F. (Uppsala University) ; Patel, Sagar S. (University of Utah) ; Perales, Miguel-Angel (Memorial Sloan Kettering Cancer Center) ; Prestidge, Tim (Starship Children's Hospital (Auckland, Nova Zelanda)) ; Qayed, Muna (Emory University School of Medicine) ; Romee, Rizwan (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Schoemans, Hélène (University Hospitals Leuven (Bèlgica)) ; Seo, Sachiko (Dokkyo Medical University) ; Sharma, Akshay (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ; Solh, Melhem (Northside Hospital) ; Strair, Roger (Rutgers University) ; Teshima, Takanori (Hokkaido University Hospital) ; Urbano-Ispizua, Alvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Van der Poel, Marjolein (Maastricht University Medical Center) ; Vij, Ravi (Washington University School of Medicine) ; Wagner, John L. (Thomas Jefferson University) ; William, Basem (The Ohio State University) ; Wirk, Baldeep (Penn State Cancer Institute) ; Yared, Jean A. (University of Maryland) ; Spellman, Steve R. (Medical College of Wisconsin) ; Arora, Mukta (University of Minnesota Medical Center) ; Hamilton, Betty K. (Cleveland Clinic Taussig Cancer Institute) ; Universitat Autònoma de Barcelona
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVHD after haploidentical hematopoietic cell transplantation (haplo-HCT) using PTCy. [...]
2020 - 10.1016/j.bbmt.2020.05.001
Biology of blood and marrow transplantation, Vol. 26 Núm. 8 (august 2020) , p. 1459-1468  
3.
8 p, 440.5 KB Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation : A Report on Behalf of the American Society for Transplantation and Cellular Therapy / Kharfan-Dabaja, Mohamed A. (Mayo Clinic. Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program) ; Kumar, Ambuj (Program for Comparative Effectiveness Research. Morsani College of Medicine. University of South Florida) ; Ayala, Ernesto (Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program. Mayo Clinic) ; Aljurf, Mahmoud (Department of Adult Hematology and Stem Cell Transplantation. King Faisal Specialist Hospital and Research Centre) ; Nishihori, Taiga (Department of Blood and Marrow Transplantation and Cellular Immunotherapy. Moffitt Cancer Center) ; Marsh, Rebecca (Cincinnati Children's Hospital Medical Center) ; Burroughs, Laura M. (Fred Hutchinson Cancer Research Center) ; Majhail, Navneet (Blood and Marrow Transplant Program. Taussig Cancer Institute. Cleveland Clinic) ; Al-Homsi, Ahmad Samer (NYU Langone Health) ; Al-Kadhimi, Zaid S. (Division of Oncology and Hematology. Department of Internal Medicine. University of Nebraska Medical Center) ; Bar, Merav (Fred Hutchinson Cancer Research Center) ; Bertaina, Alice (Division of Stem Cell Transplant and Regenerative Medicine. Department of Pediatrics. Stanford University) ; Boelens, Jaap Jan (Stem Cell Transplantation and Cellular Therapies Program. Department Pediatrics. Memorial Sloan Kettering Cancer Center) ; Champlin, Richard (Department of Stem Cell Transplantation and Cellular Therapy. The University of Texas MD Anderson Cancer Center) ; Chaudhury, Sonali (Ann and Robert H. Lurie Children's Hospital of Chicago) ; DeFilipp, Zachariah (Department of Hematology-Oncology and Hematopoietic Cell Transplant and Cellular Therapy Program. Massachusetts General Hospital) ; Dholaria, Bhagirathbhai (Vanderbilt University Medical Center) ; El-Jawahri, Areej (Department of Hematology-Oncology and Hematopoietic Cell Transplant and Cellular Therapy Program. Massachusetts General Hospital) ; Fanning, Suzanne (Blood and Marrow Transplant Program. University of South Carolina School of Medicine) ; Fraint, Ellen (Stem Cell Transplantation and Cellular Therapies Program. Department Pediatrics. Memorial Sloan Kettering Cancer Center) ; Gergis, Usama (Bone Marrow Transplant and Immune Cellular Therapy. Thomas Jefferson University Hospital) ; Giralt, Sergio (Department of Medicine. Division of Hematologic Malignancies. Memorial Sloan Kettering Cancer Center Weill Cornell Medical College) ; Hamilton, Betty K. (Blood and Marrow Transplant Program. Taussig Cancer Institute. Cleveland Clinic) ; Hashmi, Shahrukh K (Department of Medicine. Sheikh Shakhbout Medical City) ; Horn, Biljana (Department of Pediatrics. Division of Hematology/Oncology. University of Florida. UF Health Shands Children's Hospital) ; Inamoto, Yoshihiro (National Cancer Center Hospital) ; Jacobsohn, David A. (Children's National Medical Center) ; Jain, Tania (Johns Hopkins University School of Medicine) ; Johnston, Laura (Stanford University School of Medicine) ; Kanate, Abraham S. (West Virginia University) ; Kansagra, Ankit (UT Southwestern Medical Center) ; Kassim, Adetola (Vanderbilt University Medical Center) ; Kean, Leslie S. (Boston Children's Hospital. Dana-Farber Cancer Institute) ; Kitko, Carrie L. (Vanderbilt University Medical Center) ; Knight-Perry, Jessica (University of Colorado School of Medicine) ; Kurtzberg, Joanne (Duke University School of Medicine) ; Liu, Hien (Moffitt Cancer Center) ; MacMillan, Margaret L (University of Minnesota Medical School) ; Mahmoudjafari, Zahra (University of Kansas Cancer Center) ; Mielcarek, Marco (Fred Hutchinson Cancer Research Center) ; Mohty, Mohamad (Sorbonne Université. INSERM. Centre de Recherche Saint-Antoine and Hôpital Saint-Antoine. Service d'Hématologie Clinique et Thérapie Cellulaire) ; Nagler, Arnon (Chaim Sheba Medical Center (Israel)) ; Nemecek, Eneida (Oregon Health & Science University) ; Olson, Timothy S. (Children's Hospital of Philadelphia (Pennsilvània)) ; Oran, Betul (The University of Texas MD Anderson Cancer Center) ; Perales, Miguel Angel (Memorial Sloan Kettering Cancer Center Weill Cornell Medical College) ; Prockop, Susan E. (Stem Cell Transplantation and Cellular Therapies Program. Department Pediatrics. Memorial Sloan Kettering Cancer Center) ; Pulsipher, Michael A. (Children's Hospital Los Angeles Cancer and Blood Disease Institute. USC Keck School of Medicine) ; Pusic, Iskra (Washington University School of Medicine) ; Riches, Marcie L. (University of North Carolina at Chapel Hill) ; Rodriguez, Cesar (Wake Forest University School of Medicine) ; Romee, Rizwan (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Rondon, Gabriela (The University of Texas MD Anderson Cancer Center) ; Saad, Ayman (The Ohio State University. Division of Hematology) ; Shah, Nina (University of California San Francisco. Department of Medicine) ; Shaw, Peter J. (The Children's Hospital at Westmead) ; Shenoy, Shalini (Washington University School of Medicine) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Talano, Julie (Children's Hospital of Wisconsin) ; Verneris, Michael R. (University of Colorado School of Medicine) ; Veys, Paul (University College London. Great Ormond Street Hospital.) ; Wagner, John E. (University of Minnesota Medical School) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Hamadani, Mehdi (Medical College of Wisconsin) ; Carpenter, Paul A. (Fred Hutchinson Cancer Research Center) ; Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras ; Universitat Autònoma de Barcelona. Departament de Medicina
Allogeneic hematopoietic cell transplantation (allo-HCT) is potentially curative for certain hematologic malignancies and nonmalignant diseases. The field of allo-HCT has witnessed significant advances, including broadening indications for transplantation, availability of alternative donor sources, less toxic preparative regimens, new cell manipulation techniques, and novel GVHD prevention methods, all of which have expanded the applicability of the procedure. [...]
2021 - 10.1016/j.jtct.2021.04.007
Transplantation and Cellular Therapy, Vol. 27 Núm. 8 (august 2021) , p. 642-649  

See also: similar author names
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.